News

Mexican patent office grants patent protection for Vigorous Solutions fast-acting sildenafil solutions

Chinese National Intellectual Property Administration grants patent protection for Vigorous Solutions novel fast-acting sildenafil solutions

Eurasian patent protection for Vigorous Solutions sildenafil solutions is granted in Russia, Turkmenistan, Belarus, Tajikistan, Azerbaijan, Kazakhstan, Kyrgyzstan, and Armenia

Israel Patent Authority issues notice of allowance for Vigorous Solutions novel sildenafil solution products

Second pharmacokinetic (PK) trial in humans is completed, confirming Vigorous Solutions formulation as the fastest absorbed and highest bioavailable Sildenafil product

Vigorous Solutions receives a second U.S. patent allowance, issued to expand the protection of its proprietary liquid sildenafil formulations

Vigorous Solutions is issued its first U.S. patent allowance, covering an expansive variety of liquid solutions

European patent registers Vigorous Solutions product in all 38 European countries

Grant Patent issued to Vigorous Solutions by the European Patent Office

First pharmacokinetic (PK) trial in humans is completed, confirming Vigorous Solutions formulation’s superiority in time-to-absorption vs Pfizer’s Viagra^®.

Vigorous Solutions receives a patent allowance in South Africa encompassing a variety of its liquid solutions

Vigorous Solutions successfully secures $3 Million in seed funding from private investors